Research Institute of Epidemiology, Microbiology and Infectious Diseases, Tashkent 100133, Republic of Uzbekistan.
Gut Pathog. 2010 Dec 9;2(1):18. doi: 10.1186/1757-4749-2-18.
Shigella is a frequent cause of bacterial dysentery in the developing world. Treatment with effective antibiotics is recommended for shigellosis, but options become limited due to globally emerging resistance. One of the mechanisms for the development of resistance utilizes integrons. This study described the antibiotic susceptibility and the presence of class 1 and 2 integrons in S. flexneri and S. sonnei isolated in Uzbekistan.
We studied 31 isolates of S. flexneri and 21 isolates of S. sonnei isolated in Uzbekistan between 1992 and 2007 for the susceptibility or resistance to ampicillin (Am), chloramphenicol (Cl), tetracycline (Te), co-trimoxazole (Sxt), kanamycin (Km), streptomycin (Str), gentamicin (Gm), cefazolin (Czn), cefoperazone (Cpr), cefuroxime (Cur), ceftazidime (Ctz), nalidixic acid (NA) and ciprofloxacin (Cip). Am/Str/Cl/Te and Am/Str/Cl/Te/Sxt resistance patterns were found most frequently in S. flexneri. Single isolates were resistant to aminoglycoside, quinolones and cephalosporins. The resistance patterns were different in the two species. Integrons were detected in 93.5% of S. flexneri (29/31) and 81.0% of S. sonnei (17/21) isolates. In addition, 61.3% of S. flexneri (19/31) isolates and 19.0% of S. sonnei (4/21) isolates carried both classes of integrons. In 29.0% of S. flexneri (9/31) isolates, only class 1 integrons were identified. In S. flexneri isolates, the presence of class 1 integrons was associated with resistance to ampicillin and chloramphenicol. Only Class 2 integrons were present in 61.9% of S. sonnei (13/21) isolates.
Our study documents antibiotic resistance among Shigella spp. in Uzbekistan. Ninety percent of Shigella strains were resistant to previously used antibiotics. Differences among S. flexneri and S. sonnei isolates in patterns of antimicrobial resistance to routinely used shigellosis antibiotics were observed. The majority of S. flexneri were resistant to ampicillin, chloramphenicol, tetracycline and streptomycin. Class 1 and 2 integrons were widely present in these Shigella strains. Resistance to ampicillin/chloramphenicol was associated with the presence of class 1 integrons. Though several mechanisms are possible, the resistance of Shigella isolates to ampicillin/chloramphenicol may be associated with the expression of genes within class 1 integrons.
志贺菌是发展中国家细菌性痢疾的常见病因。志贺菌病推荐使用有效抗生素治疗,但由于全球耐药性的出现,选择变得有限。其中一种耐药机制是利用整合子。本研究描述了在 1992 年至 2007 年间在乌兹别克斯坦分离的福氏志贺菌和宋内志贺菌对氨苄西林(Am)、氯霉素(Cl)、四环素(Te)、复方新诺明(Sxt)、卡那霉素(Km)、链霉素(Str)、庆大霉素(Gm)、头孢唑啉(Czn)、头孢哌酮(Cpr)、头孢呋辛(Cur)、头孢他啶(Ctz)、萘啶酸(NA)和环丙沙星(Cip)的敏感性和整合子的存在情况。福氏志贺菌中最常发现 Am/Str/Cl/Te 和 Am/Str/Cl/Te/Sxt 耐药模式。单个分离株对氨基糖苷类、喹诺酮类和头孢菌素类药物有耐药性。两种志贺菌的耐药模式不同。在 93.5%(29/31)的福氏志贺菌和 81.0%(17/21)的宋内志贺菌分离株中检测到整合子。此外,61.3%(19/31)的福氏志贺菌和 19.0%(4/21)的宋内志贺菌分离株携带两类整合子。在 29.0%(9/31)的福氏志贺菌分离株中,仅鉴定出一类整合子。在福氏志贺菌分离株中,存在 1 类整合子与对氨苄西林和氯霉素的耐药性相关。只有 61.9%(13/21)的宋内志贺菌分离株存在 2 类整合子。
本研究记录了乌兹别克斯坦志贺菌属的抗生素耐药情况。90%的志贺菌菌株对以前使用的抗生素有耐药性。观察到福氏志贺菌和宋内志贺菌分离株对抗生素的耐药模式存在差异。福氏志贺菌对氨苄西林、氯霉素、四环素和链霉素耐药率较高。1 类和 2 类整合子广泛存在于这些志贺菌株中。对氨苄西林/氯霉素的耐药性与 1 类整合子的存在有关。虽然可能有几种机制,但志贺菌分离株对氨苄西林/氯霉素的耐药性可能与 1 类整合子内基因的表达有关。